Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Dual cytoplasmic and nuclear distribution of the novel arsenite-stimulated human ATPase (hASNA-I).

Kurdi-Haidar B, Hom DK, Flittner DE, Heath D, Fink L, Naredi P, Howell SB.

J Cell Biochem. 1998 Oct 1;71(1):1-10.

PMID:
9736449
2.

Isolation of the ATP-binding human homolog of the arsA component of the bacterial arsenite transporter.

Kurdi-Haidar B, Aebi S, Heath D, Enns RE, Naredi P, Hom DK, Howell SB.

Genomics. 1996 Sep 15;36(3):486-91.

PMID:
8884272
3.

Enhancement of drug sensitivity of human malignancies by epidermal growth factor.

Kröning R, Jones JA, Hom DK, Chuang CC, Sanga R, Los G, Howell SB, Christen RD.

Br J Cancer. 1995 Sep;72(3):615-9.

4.

Signaling and drug sensitivity.

Christen RD, Isonishi S, Jones JA, Jekunen AP, Hom DK, Kröning R, Gately DP, Thiebaut FB, Los G, Howell SB.

Cancer Metastasis Rev. 1994 Jun;13(2):175-89. Review.

PMID:
7923549
5.

Cellular pharmacology of dichloro(ethylenediamine)platinum(II) in cisplatin-sensitive and resistant human ovarian carcinoma cells.

Jekunen AP, Hom DK, Alcaraz JE, Eastman A, Howell SB.

Cancer Res. 1994 May 15;54(10):2680-7.

7.

Enhancement of the cytotoxicity of cisplatin by the cholecystokinin antagonist MK-329 in a human pancreatic cancer cell line.

Jamshidipour R, Pinho EB, Hom DK, Howell SB.

Cancer Chemother Pharmacol. 1994;34(6):484-90.

PMID:
7923559
8.

Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro.

Jekunen AP, Shalinsky DR, Hom DK, Albright KD, Heath D, Howell SB.

Biochem Pharmacol. 1993 May 25;45(10):2079-85.

PMID:
8512589
9.

Modulation of cisplatin sensitivity and growth rate of an ovarian carcinoma cell line by bombesin and tumor necrosis factor-alpha.

Isonishi S, Jekunen AP, Hom DK, Eastman A, Edelstein PS, Thiebaut FB, Christen RD, Howell SB.

J Clin Invest. 1992 Oct;90(4):1436-42.

10.

Expression of the c-Ha-ras oncogene in mouse NIH 3T3 cells induces resistance to cisplatin.

Isonishi S, Hom DK, Thiebaut FB, Mann SC, Andrews PA, Basu A, Lazo JS, Eastman A, Howell SB.

Cancer Res. 1991 Nov 1;51(21):5903-9.

11.

Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatin.

Christen RD, Hom DK, Porter DC, Andrews PA, MacLeod CL, Hafstrom L, Howell SB.

J Clin Invest. 1990 Nov;86(5):1632-40.

12.

Dipyridamole enhancement of etoposide sensitivity.

Howell SB, Hom DK, Sanga R, Vick JS, Chan TC.

Cancer Res. 1989 Aug 1;49(15):4147-53.

Supplemental Content

Support Center